| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |